Tracer library / [188Re]Re-tricarbonyl(cyclopentadienylcarbonate)rhenium
[188Re]Re-tricarbonyl(cyclopentadienylcarbonate)rhenium
Also written as [Re-188]tricarbonyl(cyclopentadienylcarbonate)rhenium
- Radionuclide
- Re-188 t½ 1020 min
- Modality
- Therapy
- Production route
- —
- Stage
- Preclinical
- Syntheses indexed
- 1
What it is
- Compound class
- organorhenium tricarbonylcyclopentadienyl (CpTR) radiolabeling reagent/chelate for antibody fragments and peptides
- Target / mechanism
- —
- Clinical application
- Radiolabeled antibody fragments (Fab) for targeted radiotherapy/imaging with reduced renal radioactivity accumulation PMID 17226973
- Theranostic pair
- —
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| — | — | — | 15-20% | — | Hynic conjugated MORF | 15208502 2004 Nucl Med Commun |
Need this precursor?We can point you to suppliers for [188Re]Re-tricarbonyl(cyclopentadienylcarbonate)rhenium, or handle the enquiry for you.
Get in touchNotes
Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty.